Skip to content
Screener

Bio-Techne TECH CN — Revenue

Other geography segments

US
$181.92M
GB
$12.85M

Similar metrics at other companies

Ceco Environmental logo
CECOCN — Revenue
$14.56M-1.6%
Photronics logo
PLABCN — Revenue
$60.6M+3.2%
AMB
AMBQCN — Revenue
$11.65M+108%
Mesa Laboratories logo
MLABCN — Revenue
$4.06M-19.5%
NetSol Technologies logo
NTWKCN — Revenue
$4.26M-17.9%
AXT
AXTICN — Revenue
$16.57M+23.4%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
United States$167,479$181,921$469,276$506,842
EMEA, excluding United Kingdom73,44666,501213,928195,956
United Kingdom14,89112,85241,82440,039
APAC, excluding Greater China21,82021,24563,70958,377
Greater China26,01224,48377,14973,557
Rest of World7,7679,17927,96127,900
Net sales$311,415$316,181$893,847$902,671

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's CN — revenue?
Bio-Techne (TECH) reported CN — revenue of $26.01M in Q1 2026.
How has Bio-Techne's CN — revenue changed year-over-year?
Bio-Techne's CN — revenue increased by 6.2% year-over-year, from $24.48M to $26.01M.
What is the long-term trend for Bio-Techne's CN — revenue?
Over 3 years (2022 to 2025), Bio-Techne's CN — revenue has grown at a -3.7% compound annual growth rate (CAGR), from $112.44M to $100.46M.
What does CN — revenue mean?
This metric represents the total revenue generated from contracts with customers within the specified geographic or operational segment, excluding any sales-related taxes. It serves as a primary indicator of the segment's core commercial performance and market demand. By stripping out tax impacts, it allows for a cleaner assessment of organic growth trends and pricing power.

Ask your AI about Bio-Techne's cn — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude